Ohe M - Search Results

1

Intracardiac conduction time as a predictor of cardiac resynchronization therapy response: Results of the BIO|SELECT pilot study.

Soejima K, Kondo Y, Sasaki S, Adachi K, Kato R, Hagiwara N, Harada T, Kusano K, Miura F, Morishima I, Yoshitani K, Yotsukura A, Fujimoto M, Nishii N, Shimeno K, Ohe M, Tasaka H, Sasaki H, Schrader J, Ando K. Soejima K, et al. Among authors: ohe m. Heart Rhythm O2. 2021 Sep 28;2(6Part A):588-596. doi: 10.1016/j.hroo.2021.09.007. eCollection 2021 Dec. Heart Rhythm O2. 2021. PMID: 34988503 Free PMC article.

2

Importance of nonpulmonary vein foci in catheter ablation for paroxysmal atrial fibrillation.

Hayashi K, An Y, Nagashima M, Hiroshima K, Ohe M, Makihara Y, Yamashita K, Yamazato S, Fukunaga M, Sonoda K, Ando K, Goya M. Hayashi K, et al. Among authors: ohe m. Heart Rhythm. 2015 Sep;12(9):1918-24. doi: 10.1016/j.hrthm.2015.05.003. Epub 2015 May 8. Heart Rhythm. 2015. PMID: 25962801 Free article.

3

Impact of Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Sick Sinus Syndrome　- Important Role of Non-Pulmonary Vein Foci.

Hayashi K, Fukunaga M, Yamaji K, An Y, Nagashima M, Hiroshima K, Ohe M, Makihara Y, Yamashita K, Ando K, Iwabuchi M, Goya M. Hayashi K, et al. Among authors: ohe m. Circ J. 2016;80(4):887-94. doi: 10.1253/circj.CJ-15-1384. Epub 2016 Mar 2. Circ J. 2016. PMID: 26936115 Free article. Clinical Trial.

4

Impact of catheter ablation of ventricular tachycardia in patients with prior myocardial infarctions.

Fukunaga M, Goya M, Hiroshima K, Hayashi K, Ohe M, Makihara Y, Nagashima M, An Y, Shirai S, Ando K, Yokoi H, Iwabuchi M. Fukunaga M, et al. Among authors: ohe m. J Arrhythm. 2016 Dec;32(6):462-467. doi: 10.1016/j.joa.2016.03.001. Epub 2016 Apr 20. J Arrhythm. 2016. PMID: 27920830 Free PMC article.

5

Ostial atresia of the coronary sinus in patients with supraventricular arrhythmias.

Hiroshima KI, Goya M, Nagashima M, Fukunaga M, Ohe M, An Y, Makihara Y, Hayashi K, Ando K. Hiroshima KI, et al. Among authors: ohe m. J Arrhythm. 2019 May 16;35(3):554-557. doi: 10.1002/joa3.12189. eCollection 2019 Jun. J Arrhythm. 2019. PMID: 31293708 Free PMC article.

6

Long-term efficacy and safety of anticoagulation after atrial ﬁbrillation ablation: data from the JACRE registry.

Inoue K, Hirao K, Kumagai K, Kimura M, Miyauchi Y, Tsushima E, Ohishi M, Kimura K, Yasaka M, Yamaji H, Okawa K, Fujimoto M, Morishima I, Mine T, Shimizu W, Ohe M, Okumura K; JACRE Investigators. Inoue K, et al. Among authors: ohe m. J Cardiol. 2021 Mar;77(3):263-270. doi: 10.1016/j.jjcc.2020.09.001. Epub 2020 Oct 1. J Cardiol. 2021. PMID: 33011056 Free article.

7

Lead extractions in patients with cardiac implantable electronic device infections: Single center experience.

Goya M, Nagashima M, Hiroshima K, Hayashi K, Makihara Y, Fukunaga M, An Y, Ohe M, Yamazato S, Sonoda K, Yamashita K, Katayama K, Ito T, Niu H, Ando K, Yokoi H, Iwabuchi M. Goya M, et al. Among authors: ohe m. J Arrhythm. 2016 Aug;32(4):308-12. doi: 10.1016/j.joa.2016.02.004. Epub 2016 Mar 22. J Arrhythm. 2016. PMID: 27588155 Free PMC article.

8

Identification of causative organism in cardiac implantable electronic device infections.

Fukunaga M, Goya M, Nagashima M, Hiroshima K, Yamada T, An Y, Hayashi K, Makihara Y, Ohe M, Ichihashi K, Ohtsuka M, Miyazaki H, Ando K. Fukunaga M, et al. Among authors: ohe m. J Cardiol. 2017 Nov;70(5):411-415. doi: 10.1016/j.jjcc.2017.03.006. Epub 2017 Apr 25. J Cardiol. 2017. PMID: 28454777 Free article.

9

Transvenous extraction of advisory implantable cardioverter defibrillator leads with a relatively long implant duration.

Goya M, Nagashima M, Hiroshima KI, Hayashi K, Makihara Y, Fukunaga M, An Y, Ohe M, Sasaki T, Shiohira S, Shirai Y, Kawabata M, Ando K, Isobe M, Hirao K. Goya M, et al. Among authors: ohe m. J Cardiol. 2018 Oct;72(4):316-320. doi: 10.1016/j.jjcc.2018.03.007. Epub 2018 Apr 25. J Cardiol. 2018. PMID: 29705082 Free article.

10

Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment.

Inage T, Yoshida T, Hiraki T, Ohe M, Takeuchi T, Nagamoto Y, Fukuda Y, Gondo T, Imaizumi T. Inage T, et al. Among authors: ohe m. Europace. 2008 Mar;10(3):379-83. doi: 10.1093/europace/eum297. Epub 2008 Jan 28. Europace. 2008. PMID: 18227354 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters